GSM Treatment: Vaginal Estrogen Explained
Genitourinary syndrome of menopause (GSM) affects 50 to 80% of postmenopausal women but only 7% of those diagnosed are prescribed its safest fix, vaginal estrogen (37:09, 11:00). The FDA dropped a 27-year boxed warning on low-dose vaginal estrogen in November 2025, and OB-GYN Dr. Mary Claire Haver says the condition is cheap and almost always treatable.